en

TH CN

Home
About Us
Our Story

Our Business

Message from CEO

Management Structure

Organization Chart

Board of Directors

Audit Committee

Nomination and Remuneration Committee

Risk Management Committee

Executive Committee

Management Team

Awards and Certificates
Services
Health Check Up

Intrauterine Insemination (IUI)

Intracytoplasmic Sperm Injection (ICSI)

Preimplantation Genetic Testing (PGT)

Embryo Transfer

Fertility Preservation

Other Infertility Treatments

Preventive and Regenerative Medicine
Our Specialist
Medical Professional Team

Embryology Team

Genetic Team

Nurse Team
Why Us
Investor Relations
IR Home

Financial Info

Financial Highlights

Quarterly Updates

Stock Info

Stock Quote

Investment Calculator

Shareholder Info

Dividend Information

IR Newsroom

SET Announcements

Publications

Prospectus

Resource Center

Information Inquiry

IR Contact

News Subscription
Sustainability
Sustainability Overview

Environmental

Social

Governance

Whistleblowing
News Center
Success Stories

Knowledge

Promotions

News & Activities

Sustainability Activities
Careers
Contact Us

Quarterly Updates

Home
Investor Relations
Financial Info
Quarterly Updates

Year:

2024

Quarter 1

Quarter 2

Quarter 3

Full Year

Financial Statement

Quarter 1

Quarter 2

Quarter 3

Yearly

Management Discussion and Analysis

Quarter 1

Quarter 2

Quarter 3

Yearly

Inspire IVF Public Company Limited

Ploenchit Centre Floor 5^th, Room Number 05 - 10B, Sukhumvit Soi 2, Klongtoey, Bangkok 10110

Email: info@inspireivf.com

Phone: +66 (2) 251-8666

Hot Line Nurse: +66 (0) 62-786-8666

Hot Line Customer Service: +66 (0) 63-531-8666

Services

Health Check Up
Intrauterine Insemination (IUI)
Intracytoplasmic Sperm Injection (ICSI)
Preimplantation Genetic Testing (PGT)
Embryo Transfer
Fertility Preservation
Other Infertility Treatments
Preventive and Regenerative Medicine

Certificates

Copyright © 2024 Inspire IVF Public Company Limited. All right reserved

Terms and Conditions
Privacy Notice
Cookie Policy
Sitemap

Financial Statement Quarter 3/2024

Report of the Auditor

Financial Statement

Note to Financial Statement